Position in DXCM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,776,000
-$3,146,755 QoQ
Shares Held
160,000
+0.3% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
1.02%
of 13F equity value
Holder Rank
#198
of 966 holders
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Rhenman & Partners Asset Management AB holds $158,018,251 across 15 Medical Devices names. DXCM ranks #8 (6.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
260,000 | $23,519,600 | |
| 2 | SYK |
Stryker Corp
|
65,000 | $20,464,600 | |
| 3 | BSX |
Boston Scientific Corp
|
450,500 | $19,227,340 | |
| 4 | GKOS |
GLAUKOS Corp
|
119,000 | $16,631,440 | |
| 5 | AVR |
Anteris Technologies Global Corp.
|
1,538,625 | $15,155,456 | |
| 6 | LIVN |
LivaNova PLC
|
164,000 | $13,485,720 | |
| 7 | MDT |
Medtronic plc
|
145,000 | $11,343,350 | |
| 8 | DXCM |
Dexcom Inc
This page
|
160,000 | $10,776,000 |
All Filings in DXCM
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,776,000 | 160,000 | Shares | Sole | 2026-08-13 | |
| 2025-06-30 | $13,922,755 | 159,500 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $10,584,950 | 155,000 | Shares | Sole | 2025-05-14 | |
| 2024-09-30 | $5,832,480 | 87,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $13,265,460 | 117,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $19,209,950 | 138,500 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $13,649,900 | 110,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,198,500 | 45,000 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||